Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physiological enzyme and protein cofactors are non-protein chemical compounds or metallic ions required for an enzyme's activity as a catalyst (Source: NCBI, Bookshelf NBK545242). They are broadly classified into inorganic ions and complex organic molecules called coenzymes, which are often derived from vitamins (Source: Wikipedia, "Cofactor (biochemistry)"). These substances are vital for fundamental biological processes, including cellular respiration, DNA repair, and signal transduction (Source: PMC4549098). While not traditional therapeutic targets like receptors, they are central to pharmacology; for instance, Methotrexate acts by inhibiting dihydrofolate reductase, thereby disrupting the folate cofactor cycle (Source: PubChem, CID 126941). Deficiencies in these cofactors result in various pathologies, such as scurvy or megaloblastic anemia, while their overabundance or metabolic inhibition is leveraged in treating infections and cancer (Source: StatPearls, "Vitamin Deficiency"). Furthermore, metal ions like zinc and magnesium serve as structural and catalytic components in thousands of human proteins (Source: NIH, "Magnesium Fact Sheet"). Therapeutic intervention often involves the administration of these cofactors to restore normal physiological function or the use of antagonists to halt disease progression (Source: PubMed, PMID 25100611).
Drugs typically act by supplementing deficient cofactors, competitively inhibiting cofactor binding sites on enzymes, or blocking the biosynthetic pathways of essential cofactors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological enzyme and protein cofactors.